DIFFUSION PHARMACEUTICALS IN (DFFN) Stock Analyst Earnings Estimates
NASDAQ:DFFN - Nasdaq - US2537484048 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 347.75% | N/A 61.48% | N/A 35.71% | N/A 24.89% | N/A 8.55% | ||||||||||
| EBITDA YoY % growth | -7.62M | -6.4M 16.01% | -18.34M -186.56% | -11.28M 38.50% | -11.92M -5.67% | -11.45M 3.94% | -15.872M -38.62% | -15.945M -0.46% | -15.972M -0.17% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.19M | -6.41M 21.73% | -18.37M -186.58% | -11.35M 38.21% | -12.03M -5.99% | -11.55M 3.99% | -15.975M -38.31% | -16.038M -0.40% | -15.972M 0.41% | N/A -12.40% | N/A -8.52% | N/A 19.45% | N/A 58.95% | N/A 90.22% | N/A 769.14% | N/A 140.09% | N/A 25.46% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -275.50 73.52% | -107.50 60.98% | -13.00 87.91% | -8.50 34.62% | N/A 4.84% | N/A 7.57% | N/A 13.10% | N/A 76.30% | N/A 59.60% | N/A 91.80% | N/A 900.00% | N/A 135.00% | N/A 25.53% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -1.99 -45.18% | -2.01 10.45% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -1.37 8.67% | -2.10 | 0.73 | 34.80% |
| Q2 2022 Q2Q % growth | -2.06 -3.00% | -2.08 | 0.02 | 1.00% |
| Q1 2022 Q2Q % growth | -2.22 26.00% | -1.79 | -0.44 | -24.37% |
| Q4 2021 Q2Q % growth | -2.00 33.33% | -2.04 | 0.04 | 1.96% |
| Q3 2021 Q2Q % growth | -1.50 57.14% | -2.04 | 0.54 | 26.47% |
| Q2 2021 Q2Q % growth | -2.00 33.33% | -2.30 | 0.29 | 12.85% |
| Q1 2021 Q2Q % growth | -3.00 14.29% | -2.30 | -0.71 | -30.72% |
| Q4 2020 Q2Q % growth | -3.00 45.45% | -2.55 | -0.45 | -17.65% |
| Q3 2020 Q2Q % growth | -3.50 88.33% | -2.81 | -0.69 | -24.78% |
| Q2 2020 Q2Q % growth | -3.00 90.48% | -2.81 | -0.19 | -6.95% |
| Q1 2020 Q2Q % growth | -3.50 91.36% | -4.34 | 0.84 | 19.26% |
| Q4 2019 Q2Q % growth | -5.50 | -6.89 | 1.38 | 20.12% |
| Q3 2019 Q2Q % growth | -30.00 | -36.21 | 6.21 | 17.15% |
| Q2 2019 Q2Q % growth | -31.50 | -35.19 | 3.69 | 10.49% |
| Q1 2019 Q2Q % growth | -40.50 | -46.16 | 5.66 | 12.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |